The discovery of 106 immune signatures, particularly five key associations such as CD25 on IgD- CD24- cells in SCLC and CCR2 on monocyte cells in LUSC, enriches our understanding of these cells’ causal involvement in lung cancer. This evidence concerns the gene CCR2 and small cell lung carcinoma.